StockData
Envoy Medical, Inc. logo

Envoy Medical, Inc. (COCH) shareholders

COCHNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as COCHW
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$6.87−0.05 (-0.72%)

Close on Nov 17, 2026Market cap $530.33MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
25M
Shares held, 13F filers
Institutional holders
32
7 new, 7 sold out
Net institutional buying
8M
In Q2 2026
Insider trades, 12 months
6 buys · 0 sales
Net bought $8.17M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Glen A. Taylor68,909,61484.80%13D (active) amendmentFeb 12, 2026
Bleichroeder Holdings LLC
Joint filing with Bleichroeder LP (9.99%), Andrew Gundlach (9.99%)
7,839,0009.99%13G (passive)Mar 31, 2026
Nantahala Capital Management, LLC
Joint filing with Wilmot B. Harkey (9.99%), Daniel Mack (9.99%)
7,683,7989.99%13G (passive)Mar 31, 2026
Anzu SPAC GP I LLC2,718,84111.33%13D (active)Sep 29, 2023
Waqas Khatri
Joint filing with Ayrton Capital LLC (7.87%), Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B (7.87%)
2,457,9637.87%13G (passive)Dec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of COCHValueChange% of portfolio
Nantahala Capital Management, LLC15,300,000–$11.92M+7,650,0000.20%
Bleichroeder LP6,250,000–$4.95M–0.89%
Vanguard Capital Management LLC880,214–$697.13K−1,4580.00%
DSG Capital Advisors, LLC625,000–$474.19K–0.07%
Geode Capital Management, LLC541,729–$429.07K+19,9050.00%
Focus Partners Wealth425,310–$336.85K+212,6550.00%
Vanguard Fiduciary Trust Co296,679–$234.97K+1,9580.00%
UBS Group AG190,838–$151.14K+120,3790.00%
Arcus Capital Partners, LLC187,573–$148.56K–0.06%
ExodusPoint Capital Management, LP182,354–$144.42KNew0.00%
Northern Trust Corp109,466–$86.70K−1,5840.00%
Morgan Stanley90,921–$72.01K+17,0210.00%
CIBC Bancorp USA Inc.77,887–$61.69K–0.00%
LPL Financial LLC48,401–$38.33K+20,0000.00%
Jane Street Group, LLC31,223–$24.73KNew0.00%
Meteora Capital, LLC28,051–$22.22K–0.00%
State Street Corp23,872–$18.91K–0.00%
XTX Topco Ltd17,146–$13.58KNew0.00%
Afg Fiduciary Services Limited Partnership12,000–$9.02K–0.01%
BlueStem Wealth Partners, LLC10,454–$8.28K–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares heldNew / addedReduced / closedShares boughtShares sold
Q2 20263225M7 / 73 / 78M0M
Q1 20263317M14 / 62 / 616M0M
Q4 2025272M6 / 94 / 70M1M
Q3 2025282M7 / 46 / 00M0M
Q2 2025222M1 / 25 / 10M0M
Q1 2025222M1 / 64 / 20M0M
Q4 2024242M9 / 43 / 31M0M
Q3 2024181M4 / 42 / 50M0M
Q2 2024201M8 / 34 / 50M0M
Q1 2024171M11 / 32 / 30M1M
Q4 202392M9 / 00 / 02M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

9 funds held COCH in Q1 2026, 90% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of COCHValue% of fundAs of
Vanguard Extended Market Index Fund606,649–$480.47K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund319,000–$225.05K0.00%May 31, 2026
Vanguard Total Stock Market Index Fund273,565–$216.66K0.00%Jun 30, 2026
Fidelity Series Total Market Index Fund64,956–$45.83K0.00%May 31, 2026
Fidelity Nasdaq Composite Index Fund38,330–$27.04K0.00%May 31, 2026
Fidelity Total Market Index Fund37,415–$26.40K0.00%May 31, 2026
Blackstone Alternative Multi-Strategy Fund-1,500–-$1.19K-0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares ownedLatest filing
Brent T. LucasChief Executive Officer, Director342,666Jun 23, 2026
Robert PotashnickCAO & VP of Finance212,500Aug 26, 2026
Chas McKhannDirector–Apr 17, 2026
Charles BrynelsenDirector1,050,000Feb 17, 2026
Mona Chetan PatelDirector332,500Feb 17, 2026
Susan KantorDirector174,037Feb 17, 2026
Michael Curtis CroweDirector–Dec 5, 2025
Janis Smith-GomezDirector–Dec 5, 2025
Glen A. Taylor10% owner29,040,049Feb 17, 2026
SPAC GP I. LLC Anzu10% owner2,490,000Dec 26, 2024
Whitney Haring-Smith10% owner11,500,000Dec 26, 2024

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Brent T. Lucas
Chief Executive Officer, Director
May 29, 2026Award+32,856$0.60$19.71K329,946
Charles Brynelsen
Director
Feb 12, 2026Buy+1,000,000$0.40$400.00K1,050,000
Susan Kantor
Director
Feb 12, 2026Buy+96,150$0.40$38.46K174,037
Mona Chetan Patel
Director
Feb 12, 2026Buy+312,500$0.40$125.00K332,500
Brent T. Lucas
Chief Executive Officer, Director
Feb 12, 2026Buy+62,500$0.40$25.00K297,090
Robert Potashnick
Interim CFO
Feb 12, 2026Buy+212,500$0.40$85.00K212,500
Glen A. Taylor
10% owner
Feb 12, 2026Buy+18,750,000$0.40$7.50M21,703,607
Brent T. Lucas
Chief Executive Officer, Director
Nov 28, 2025Award+18,105$0.71$12.85K234,590
Mona Chetan Patel
Director
Jun 11, 2025Buy+2,500$1.47$3.68K20,000
Mona Chetan Patel
Director
Jun 6, 2025Buy+10,000$1.46$14.60K17,500
Brent T. Lucas
Chief Executive Officer, Director
May 30, 2025Award+7,742$1.29$9.99K216,485
Charles Brynelsen
Director
May 27, 2025Buy+35,000$1.65$57.75K50,000
Charles Brynelsen
Director
May 23, 2025Buy+13,000$1.64$21.32K15,000
Charles Brynelsen
Director
May 22, 2025Buy+2,000$1.68$3.36K2,000
Susan Kantor
Director
Dec 23, 2024Other+34,705––77,887
SPAC GP I. LLC Anzu
10% owner
Dec 23, 2024Other−2,028,986––0
SPAC GP I. LLC Anzu
10% owner
Dec 20, 2024Conversion+1,028,986––2,028,986
Brent T. Lucas
Chief Executive Officer, Director
Nov 30, 2024Award+5,165$1.94$10.02K208,743
Mona Chetan Patel
Director
Nov 20, 2024Buy+2,500$2.28$5.70K7,500
Whitney Haring-Smith
10% owner
Nov 19, 2024Other−1,000,000––1,000,000
Susan Kantor
Director
Nov 19, 2024Other+18,182––43,182
Mona Chetan Patel
Director
Sep 11, 2024Buy+4,000$3.33$13.32K5,000
Mona Chetan Patel
Director
Sep 9, 2024Buy+1,000$3.20$3.20K1,000
Brent T. Lucas
Chief Executive Officer, Director
Jun 24, 2024Other+10,176––12,720
Brent T. Lucas
Chief Executive Officer, Director
Jun 24, 2024Other+74,784––195,615
Brent T. Lucas
Chief Executive Officer, Director
Nov 21, 2023Buy+2,380$0.92$2.19K120,831
Brent T. Lucas
Chief Executive Officer, Director
Nov 21, 2023Buy+10,000$0.98$9.80K118,451
Diane L. Dewbrey
Director
Sep 29, 2023Conversion+25,000––25,000
Priya Cherian Huskins
Director
Sep 29, 2023Conversion+25,000––25,000
Daniel J. Hirsch
CFO and Corporate Secretary, Director
Sep 29, 2023Conversion+25,000––25,000
SPAC GP I. LLC Anzu
10% owner
Sep 29, 2023Conversion+2,490,000––2,490,000
SPAC GP I. LLC Anzu
10% owner
Sep 29, 2023Other−490,000––2,000,000
Susan Kantor
Director
Sep 29, 2023Conversion+25,000––25,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
2.7
At 0M shares a day
Change since last report
-84.4%
From 1M shares
Short volume, 20 days
64.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Envoy Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,808 shares on Aug 31, 2026 over the last 90 days.

See a number that looks wrong?